SANGAMO THERAPEUTICS, INC.
SGMO · NASDAQ
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, cell therapy, and genome engineering.
Market Data
Price
$0.15
+0.00 (+3.26%)
Market Cap$58M
P/E Ratio—
EPS$—
52W High$0.76
52W Low$0.03
Beta0.19
Data from Finnhub · Updated Oct 8, 2026